Compendium of Cancer Genome Aberrations

HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 2,229: Line 2,229:
|-
|-
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|Indolent T-cell lymphoma of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|
|Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|
|Pending
|
|
|
|
|-
|-
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|Indolent NK-cell lymphoproliferative disorder of the gastrointestinal tract||Disease|| || || || || ||SK|| ||
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Enteropathy-associated T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Enteropathy-Associated T-cell Lymphoma
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
|*Derick Okwan-Duodu, MD, PhD *Sumire Kitahara, MD
|
|Complete
|
|1/21/2021
|
|
|-
|-
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Monomorphic epitheliotropic intestinal T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Monomorphic Epitheliotropic Intestinal T-cell Lymphoma
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|Derick Okwan-Duodu MD, PhD; Sumire Kitahara, MD
|
|Pending
|
|
|
|
|-
|-
|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
|Intestinal T-cell lymphoma, NOS||Disease|| || || || || ||SK|| ||
|
|Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)
|Derick Okwan MD, PhD (Stanford Medicine, CA)  Sumire Kitahara MD (Cedars-Sinai, CA)
|Derick Okwan MD, PhD (Stanford Medicine, CA)  Sumire Kitahara MD (Cedars-Sinai, CA)
|
|Complete
|
|9/26/2022
|
|
|-
|-
|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
|Hepatosplenic T-cell lymphoma||Disease|| || || || || ||SK|| ||
|
|Hepatosplenic T-cell Lymphoma
|*Michelle Don, MD, MS
|Michelle Don, MD, MS
|
|Complete
|
|1/21/2021
|
|
|-
|-
Retrieved from "https://test.ccga.io/index.php/HAEM5:Volunteer_Assignments_and_Opportunities"